Insiders / Kewalramani Reshma

Kewalramani Reshma

CIK 1735944personinsider
Companies
1
First seen
Jan 26, 2026
Last activity
Mar 3, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Vertex Pharmaceuticals Inc / Ma · VRTXCEO98,278154,82520

All securities held

1 position · latest reported per filing
CompanySecuritySharesAs of
Vertex Pharmaceuticals Inc / MaCommon Stock98,278Feb 27, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 27, 2026SellVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$7.72M-16K
-12.81%
105,998
0.04% of shares
medium
Feb 13, 2026OtherVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$6.36M-13K
-8.90%
133,487
0.05% of shares
low
Feb 10, 2026OtherVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$3.89M-8K
-5.36%
146,528
0.06% of shares
low
Feb 17, 2026OtherVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$3.17M-7K
-4.37%
143,259
0.06% of shares
low
Feb 27, 2026SellVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$2.97M-6K
-5.66%
100,003
0.04% of shares
medium
Feb 24, 2026OtherVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$2.42M-5K
-3.48%
138,278
0.05% of shares
low
Feb 27, 2026SellVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$1.73M-3K
-2.80%
121,578
0.05% of shares
medium
Feb 27, 2026SellVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$1.60M-3K
-2.43%
131,730
0.05% of shares
medium
Feb 27, 2026SellVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$1.34M-3K
-2.08%
128,545
0.05% of shares
medium
Feb 27, 2026SellVRTX
Vertex Pharmaceuticals Inc / Ma
Common Stock
$1.24M-3K
-1.98%
125,076
0.05% of shares
medium